Article
Prognostic significance of microsatellite instability and Ki-ras mutation type in stage II colorectal cancer.
Oncology - 1 Jan 2003
Wang Cathy, van Rijnsoever Marius, Grieu Fabienne, Bydder Sean, Elsaleh Hsny, Joseph David, Harvey Jennet, Iacopetta Barry
Abstract excerpt
OBJECTIVES: The survival of stage II colorectal cancer (CRC) patients is approximately 70% at 5 years. Identification of the patient subgroup at high risk for tumour recurrence and death would allow more informed use of chemotherapy for this stage of disease. Several clinical and pathological factors have been reported to associate with worse survival. In the present study we investigated the prognostic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
